SCHEMBL10128065

SCHEMBL10128065

Cc1ccc2oc3c(-c4ccc(-c5nnc6c7ccccc7ccn56)cc4)cc(C)cc3c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.38
ALDH1A1 P00352 6/20 0.38
NUDT1 P36639 1/20 0.35
PIM1 P11309 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
PIM3 Q86V86 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
THRB P10828 2/20 0.35
KDM4E B2RXH2 7/20 0.34
KMT2A Q03164 3/20 0.34
MAOB P27338 3/20 0.33
MAOA P21397 1/20 0.33
RXFP1 Q9HBX9 3/20 0.33
POLB P06746 2/20 0.32
MEN1 O00255 1/20 0.32
ESR1 P03372 1/20 0.32
HPGD P15428 5/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10148819 0.91 MAPT (0.34) MAPTALDH1A1PIM1CSNK2A2CSNK2B
SCHEMBL10128115 0.90 MAPT (0.39) MAPTALDH1A1PIM1CSNK2A2CSNK2B
SCHEMBL10128076 0.88 MAPT (0.36) MAPTALDH1A1NUDT1CSNK2A2CSNK2B
SCHEMBL10128121 0.88 MAPT (0.35) MAPTALDH1A1NUDT1THRBKDM4E
SCHEMBL10128083 0.86 PIM1 (0.36) MAPTALDH1A1NUDT1PIM1CSNK2A2
SCHEMBL10128099 0.86 PIM1 (0.36) MAPTALDH1A1NUDT1PIM1CSNK2A2
SCHEMBL10128104 0.85 KDM4E (0.35) MAPTALDH1A1NUDT1PIM1CSNK2A2
SCHEMBL10128098 0.85 MAPT (0.34) MAPTALDH1A1PIM1CSNK2A2CSNK2B
SCHEMBL10128101 0.85 ENPP3 (0.34) MAPTALDH1A1PIM1CSNK2A2CSNK2B
SCHEMBL10128086 0.84 MAPT (0.34) MAPTALDH1A1THRBKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 MAPT 1271/4885ALDH1A1 1032/4885NUDT1 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.